Developer docs
API playgroundTry for free, no card

Search company profiles

Doxper

Full company profile

uuid0003fwf

Namestring
Doxper
Legal namestring
InformDS Technologies Private Limited
Websiteurl
doxper.com
Company typeenum
Private
Founded yearint
2015
Descriptiontext

Doxper (legally InformDS Technologies Private Limited) is a Mumbai- and Bangalore-based digital health data-capture platform founded in 2015 by IIT alumni Shailesh Prithani (CEO), Randeep Singh (CSO), and Pawan Jain (CTO). The company provides an AI-powered digital pen and encoded paper solution that allows physicians to instantly digitise handwritten prescriptions and case sheets without changing their clinical workflow, addressing the long-standing failure of EHR/EMR systems to achieve adoption in outpatient settings. Underlying technology combines Bluetooth-enabled smart pens writing on PageID-coded paper with a proprietary in-house machine learning pipeline for medical handwriting recognition (~95% initial accuracy after per-physician calibration on 100-300 prescriptions), hosted on HIPAA-compliant cloud infrastructure and integrating with existing Hospital Information Systems (HIS/EMR) via real-time contextual triggers to departments such as Admissions, Lab, Pharmacy, and Imaging. Specialty-specific structured templates span 11 clinical specialties and the platform is fully integrated with India's Ayushman Bharat Digital Mission (ABDM) for ABHA health ID creation and record linking.

Doxper monetises through a multi-stream model: annual subscriptions at Rs 15,000 per pen licence (or Rs 1,500/month auto-pay), Rs 5,000 per additional specialty template, a Rs 4-6 consumable per-sheet charge on Doxper Prints encoded paper (MOQ 1,000), and a Rs 5,000 refundable pen security deposit. Go-to-market is bifurcated: a direct enterprise field-sales motion with custom HIS/EMR integration for hospitals (signed customers include Manipal Hospitals, Wockhardt, Nanavati Max, BLK Max, KIMS, CK Birla, and Cloudnine), and a self-serve online subscription funnel with a 30-day free trial for individual clinics. A separate Real World Data & Analytics revenue line sells anonymised longitudinal Rx datasets and RWE studies to pharmaceutical and healthcare-analytics clients. According to disclosed metrics, the platform has 10,000+ doctors and 80+ hospital customers across 100+ Indian cities, with 30M+ digitised prescriptions and 1.5 crore+ post-Meddo acquisition; operations extend to Bangladesh (3,000+ doctors via a pharma partnership) and historically Korea (e-pharmacy channel via K-Startup Grand Challenge in 2018).

The company has raised approximately US$5.85 million in total disclosed funding — a $750K seed (August 2017), $1.1M pre-Series A (April 2018), and $4M Series A first close (August 2019) led by Alkemi — and in August 2021 was acquired by Gurugram-based outpatient healthtech operator Meddo in a cash-and-stock deal, under which Doxper continues to operate as a branded product within Meddo's outpatient ecosystem. Doxper holds one granted Indian patent (WO2017119004) covering its healthcare informatics storage/delivery method and has been recognised via MIT Solve (2017), Nasscom Emerge50 (2018), and HIMSS-Elsevier Asia Pacific Digital Healthcare Award finalist status (2018).

Short descriptiontext

Doxper (InformDS Technologies Private Limited) is an India-based AI-powered digital pen and encoded paper platform that lets physicians instantly digitise handwritten prescriptions and case sheets, serving hospitals, individual clinics, and pharmaceutical companies with ABDM-integrated clinical documentation and real-world data analytics.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersGurugram, India
HQ citystring
Gurugram
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
digital pen healthcare, medical handwriting recognition, healthcare data digitization, prescription digitization platform, clinical documentation software
Industry3 codes
PRIMARYHLACANAM
DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHDAAAEAD
Optical Character Recognition (OCR) & Document Vision
SECONDARYHLACANAO
DTx/SaMD Deployment, Integration & Reimbursement Enablement
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
NAICS code1 code
  • Custom Computer Programming Services541511
SIC code2 codes
  • Services-Prepackaged Software7372
  • Pens, Pencils & Other Artists' Materials3950
Product category
Healthcare Documentation Software
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Subscription Fees
TypeSubscription Recurring
Description

Annual or monthly subscription plans for digital pen license with software access. Annual plan at Rs 15,000 per annum, monthly at Rs 1,500 per month. Includes pen warranty, cloud storage, software upgrades, and ABDM services.

doxper.com
2Doxper Prints (Consumables)
TypeHardware Sales
Description

Revenue from encoded prescription paper sheets. Rs 4 for single-side A4, Rs 6 for double-side A4. Minimum order quantity 1000 prints with pan-India delivery.

doxper.com
3Template Customisation
TypeProfessional Services
Description

Additional revenue from template change fees or additional template designs at Rs 5,000 per template.

doxper.com
4Pen Security Deposit
TypeSubscription Recurring
Description

Refundable security deposit of Rs 5,000 for trial users, held until subscription conversion or pen return.

doxper.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Marketing or Sales, Personnel, Operations, Supply Chain
Pricing details4 tiers
1Free 30-day trial with Rs 5,000 refundable security deposit
ModelFreemiumBilling cadencePay-as-you-go
Notes

Includes 100 free Rx with clinic's custom design. Full refund if not satisfied within 30 days. Doxper Digital Pen with warranty, unlimited secure cloud storage, 1 structured Rx template, ABDM services included.

doxper.com
2Annual subscription - Best Value
ModelSubscriptionBilling cadenceAnnual
Notes

Rs 15,000 per annum (1 pen licence). Includes Doxper Digital Pen with warranty, unlimited cloud storage, 1 structured Rx template, intuitive software with upgrades, 2 follow-up reminder SMSes per Rx, 1 soft copy Rx SMS per Rx, pen refills, ABDM services. Additional template: Rs 5,000 per template.

doxper.com
3Monthly subscription
ModelSubscriptionBilling cadenceMonthly
Notes

Rs 1,500 per month. Requires auto-pay UPI bank mandate. Auto-renews unless cancelled. Same inclusions as annual plan.

doxper.com
4Doxper Prints - Consumables
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Rs 4 for single-side A4, Rs 6 for double-side A4. Minimum order quantity 1000 prints, delivery pan India.

doxper.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 2 records shown
1DOXPER
Description

AI-powered digital pen and encoded paper solution for healthcare digitisation, enabling doctors to instantly digitise prescriptions and case sheets without workflow change.

+1 more record
Core offering1 text field

Doxper provides an AI-powered digital pen and encoded paper solution that allows doctors to digitise handwritten prescriptions and case sheets in real-time without changing their clinical workflow. The bundled offering includes a Bluetooth-enabled digital pen (Doxper and Doxper Blu), mobile applications, a HIPAA-compliant cloud platform with specialty-specific structured templates, and integration with India's Ayushman Bharat Digital Mission (ABDM).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 96% adoption rate within 6 weeks average
+4 more records
Product overview1 text field

Doxper is a unified healthcare digitisation platform built around an ML/AI-powered digital pen and encoded paper solution. The core offering consists of the Doxper Digital Pen, DOXPER/DOXPER BLU mobile apps, and cloud-based health records platform. Specialty-specific coded paper templates support 11 medical specialties. The platform is offered through subscription plans (Classic Trial, Annual, Monthly) that bundle the pen hardware with software access, cloud storage, and ABDM services. Add-on modules include Real World Data & Analytics for pharma companies, Hospital Integration for HIS/EMR connectivity, Smart Contextual Triggers for automated care coordination, and MIS Dashboards for operational analytics. Doxper was acquired by Meddo in August 2021.

Product and service4 records
1Doxper Digital Pen & Cloud Digitisation Platform
CategoryHealthcare Digitisation Software Platform
Description

AI-powered digital pen (Doxper and Doxper Blu with Bluetooth) paired with mobile apps (DOXPER and DOXPER BLU) and a HIPAA-compliant cloud platform that captures handwritten prescriptions and case sheets in real-time via Bluetooth and stores them in a structured digital format. Sold via annual (Rs 15,000) or monthly (Rs 1,500) subscription for individual clinics and hospitals; 30-day free trial available.

2Doxper Encoded Paper (Doxper Prints)
CategoryConsumables (Encoded Paper)
Description

Coded/printed paper sheets with a unique PageID that work with the Doxper digital pen for handwriting capture. Available as single-side A4 (Rs 4) and double-side A4 (Rs 6) with a minimum order quantity of 1,000 prints and pan-India delivery. Offered with specialty-specific structured templates for Cardiology, Dental, Dermatology, ENT, Gynaecology, Internal Medicine, Neurology, Oncology, Ophthalmology, Paediatrics, and Psychiatry.

3Real World Data & Analytics Service
CategoryData Analytics Service
Description

Analytics service providing anonymised, unbiased, and longitudinal Rx insights from digitised outpatient prescriptions. Used by pharmaceutical companies for real-world evidence generation, Rx audits, brand performance tracking, KOL engagement, disease surveillance, and pharmacovigilance. Supports monthly anonymised Rx datasets and custom digitised Rx templates for therapy areas and geographies (e.g., Africa).

4ABDM Integration Services
CategoryHealthcare Compliance / Interoperability Service
Description

Integration with India's Ayushman Bharat Digital Mission enabling ABHA (Ayushman Bharat Health Account) creation and health records linking for patients. Included with subscriptions and offered as part of compliance enablement for participating healthcare providers. Doxper became one of the first tech players fully integrated with ABDM.

Scale indicator17 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

Social endeavour to bring quick and cost-effective healthcare digitisation to remote areas on outskirts of Bangalore.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2022-05-13
Description

Doxper is one of the first tech players fully integrated with India's Ayushman Bharat Digital Mission (ABDM). Participates in NHA technology partner conventions to shape India's digital health ecosystem.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2021-08-03
Description

Gurugram-based healthtech startup acquired Doxper in a cash and stock deal. Combined entity became one of India's largest healthtech players in outpatient care space with 1.5 crore+ digitised prescriptions and 1 crore+ patients.

4Pharma company partnerships (Bangladesh)
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2021-06-01
Description

Partnership with pharma company since June 2021 to sponsor Doxper solution for 3,000+ doctors in Bangladesh. Crossed 2 million Rx milestone. Scale-up to additional doctors.

doxper.com
5Korean e-pharmacy startup
Strategic tierMinorTypeChannel Partner/ Reseller/ DistributorAnnounced on2018-12-05
Description

First major overseas order and partnership secured through K-Startup Grand Challenge programme. Partnership with fast-growing e-pharmacy startup in Korea.

doxper.com
6Biocon Foundation
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2017-02-16
Description

Partnership for oral cancer screening at scale using Doxper's digital pen solution with ASHA workers. Data captured in local language (Kannada), analytics and insights generation provided. Over 5,000 patients screened.

doxper.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Practo is a broader digital health platform in India offering practice management, EMR, telemedicine, and appointments. While not a direct smart pen competitor, Practo competes in digitising Indian physicians' workflows and is a much larger incumbent in the same customer base.

2DocOn
TypeDirect peer
Description

DocOn provides digital prescription and clinic management software for Indian doctors, including smart pen-based digitisation. Directly comparable to Doxper's clinic-focused digitisation offering, serving solo practitioners and small clinics in India.

TypeBroad incumbent
Description

MFine is an Indian digital health platform offering online consultations, EMR, and AI-driven health services. Comparable as a healthcare IT player targeting Indian physicians and outpatient digitisation, though focused more on telehealth than handwriting capture.

4Napier Healthcare
TypeBroad incumbent
Description

Napier Healthcare provides hospital information systems and EMR solutions for hospitals across emerging markets including India. Comparable as a healthcare IT vendor competing for the same hospital digitisation RFPs as Doxper's enterprise offering.

TypeDirect peer
Description

Livescribe pioneered smart pen and digitised paper technology for general note-taking, the same core technology category as Doxper's smart digital pen. While Livescribe is consumer/education-focused and Doxper is healthcare-focused, they share the underlying digitised handwriting capture approach.

TypeBroad incumbent
Description

Tata 1mg is a leading Indian digital health platform with e-pharmacy, diagnostics, and physician consultation services. While broader than Doxper, it increasingly competes for outpatient digitisation workflows and physician data relationships.

TypeEmerging player
Description

CrelioHealth is a digital health platform focused on diagnostic centres and patient records management in India. Comparable as a healthtech platform serving outpatient and diagnostic workflows with overlap on patient data management.

TypeBroad incumbent
Description

Attune Technologies is a cloud-based healthcare IT platform providing HIS/EMR solutions for hospitals across India and emerging markets. A direct competitor in the hospital digitisation space where Doxper's hospital integration module competes.

TypeOthers
Description

Meddo is Doxper's parent company (acquired Aug 2021), operating an integrated outpatient care platform. Relevant as the strategic acquirer/operator of Doxper's platform and a reference point for how Doxper's technology is being commercialised in a larger healthtech context.

10HealthStack (by Clairco)
TypeDirect peer
Description

HealthStack provides digital health infrastructure including EMR/HIS solutions for Indian hospitals and clinics. Directly comparable as a healthcare digitisation platform targeting similar enterprise hospital customers as Doxper.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers15 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors6 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Doxper

Healthcare Documentation Softwaredoxper.com

Doxper (InformDS Technologies Private Limited) is an India-based AI-powered digital pen and encoded paper platform that lets physicians instantly digitise handwritten prescriptions and case sheets, serving hospitals, individual clinics, and pharmaceutical companies with ABDM-integrated clinical documentation and real-world data analytics.

What Doxper does

Doxper (legally InformDS Technologies Private Limited) is a Mumbai- and Bangalore-based digital health data-capture platform founded in 2015 by IIT alumni Shailesh Prithani (CEO), Randeep Singh (CSO), and Pawan Jain (CTO). The company provides an AI-powered digital pen and encoded paper solution that allows physicians to instantly digitise handwritten prescriptions and case sheets without changing their clinical workflow, addressing the long-standing failure of EHR/EMR systems to achieve adoption in outpatient settings. Underlying technology combines Bluetooth-enabled smart pens writing on PageID-coded paper with a proprietary in-house machine learning pipeline for medical handwriting recognition (~95% initial accuracy after per-physician calibration on 100-300 prescriptions), hosted on HIPAA-compliant cloud infrastructure and integrating with existing Hospital Information Systems (HIS/EMR) via real-time contextual triggers to departments such as Admissions, Lab, Pharmacy, and Imaging. Specialty-specific structured templates span 11 clinical specialties and the platform is fully integrated with India's Ayushman Bharat Digital Mission (ABDM) for ABHA health ID creation and record linking.

Doxper monetises through a multi-stream model: annual subscriptions at Rs 15,000 per pen licence (or Rs 1,500/month auto-pay), Rs 5,000 per additional specialty template, a Rs 4-6 consumable per-sheet charge on Doxper Prints encoded paper (MOQ 1,000), and a Rs 5,000 refundable pen security deposit. Go-to-market is bifurcated: a direct enterprise field-sales motion with custom HIS/EMR integration for hospitals (signed customers include Manipal Hospitals, Wockhardt, Nanavati Max, BLK Max, KIMS, CK Birla, and Cloudnine), and a self-serve online subscription funnel with a 30-day free trial for individual clinics. A separate Real World Data & Analytics revenue line sells anonymised longitudinal Rx datasets and RWE studies to pharmaceutical and healthcare-analytics clients. According to disclosed metrics, the platform has 10,000+ doctors and 80+ hospital customers across 100+ Indian cities, with 30M+ digitised prescriptions and 1.5 crore+ post-Meddo acquisition; operations extend to Bangladesh (3,000+ doctors via a pharma partnership) and historically Korea (e-pharmacy channel via K-Startup Grand Challenge in 2018).

The company has raised approximately US$5.85 million in total disclosed funding — a $750K seed (August 2017), $1.1M pre-Series A (April 2018), and $4M Series A first close (August 2019) led by Alkemi — and in August 2021 was acquired by Gurugram-based outpatient healthtech operator Meddo in a cash-and-stock deal, under which Doxper continues to operate as a branded product within Meddo's outpatient ecosystem. Doxper holds one granted Indian patent (WO2017119004) covering its healthcare informatics storage/delivery method and has been recognised via MIT Solve (2017), Nasscom Emerge50 (2018), and HIMSS-Elsevier Asia Pacific Digital Healthcare Award finalist status (2018).

Doxper firmographics

Firmographics
Name
Doxper
Legal name
InformDS Technologies Private Limited
Website
https://doxper.com
Company type
Private
Founded year
2015
Operating status
Acquired
Headcount range
51–100 employees
Short description
Doxper (InformDS Technologies Private Limited) is an India-based AI-powered digital pen and encoded paper platform that lets physicians instantly digitise handwritten prescriptions and case sheets, serving hospitals, individual clinics, and pharmaceutical companies with ABDM-integrated clinical documentation and real-world data analytics.
Ownership category
akta.pro rank

Doxper industry classification

Industry
Product category
Healthcare Documentation Software
NAICS
Custom Computer Programming Services (541511)
SIC
Services-Prepackaged Software (7372), Pens, Pencils & Other Artists' Materials (3950)
akta.pro industry
PRIMARYHLACANAM
DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHDAAAEAD
Optical Character Recognition (OCR) & Document Vision
SECONDARYHLACANAO
DTx/SaMD Deployment, Integration & Reimbursement Enablement
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

Keywords

  • Digital pen healthcare
  • Medical handwriting recognition
  • Healthcare data digitization
  • Prescription digitization platform
  • Clinical documentation software

Where Doxper is headquartered

Location

Headquarters

HQ city
Gurugram
HQ country
India
HQ region
Asia

Offices3 records

Markets served

Doxper business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Marketing or Sales, Personnel, Operations, Supply Chain

Revenue model

  1. Subscription Fees: Annual or monthly subscription plans for digital pen license with software access. Annual plan at Rs 15,000 per annum, monthly at Rs 1,500 per month. Includes pen warranty, cloud storage, software upgrades, and ABDM services.
  2. Doxper Prints (Consumables): Revenue from encoded prescription paper sheets. Rs 4 for single-side A4, Rs 6 for double-side A4. Minimum order quantity 1000 prints with pan-India delivery.
  3. Template Customisation: Additional revenue from template change fees or additional template designs at Rs 5,000 per template.
  4. Pen Security Deposit: Refundable security deposit of Rs 5,000 for trial users, held until subscription conversion or pen return.

Pricing tiers

ModelBillingPrice
FreemiumPay-as-you-goFree 30-day trial with Rs 5,000 refundable security deposit
SubscriptionAnnualAnnual subscription - Best Value
SubscriptionMonthlyMonthly subscription
Unit PricingPay-as-you-goDoxper Prints - Consumables

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Doxper product offering

Product offering

Core offering

Doxper provides an AI-powered digital pen and encoded paper solution that allows doctors to digitise handwritten prescriptions and case sheets in real-time without changing their clinical workflow. The bundled offering includes a Bluetooth-enabled digital pen (Doxper and Doxper Blu), mobile applications, a HIPAA-compliant cloud platform with specialty-specific structured templates, and integration with India's Ayushman Bharat Digital Mission (ABDM).

Product overview

Doxper is a unified healthcare digitisation platform built around an ML/AI-powered digital pen and encoded paper solution. The core offering consists of the Doxper Digital Pen, DOXPER/DOXPER BLU mobile apps, and cloud-based health records platform. Specialty-specific coded paper templates support 11 medical specialties. The platform is offered through subscription plans (Classic Trial, Annual, Monthly) that bundle the pen hardware with software access, cloud storage, and ABDM services. Add-on modules include Real World Data & Analytics for pharma companies, Hospital Integration for HIS/EMR connectivity, Smart Contextual Triggers for automated care coordination, and MIS Dashboards for operational analytics. Doxper was acquired by Meddo in August 2021.

Differentiator

Problem solved

Functional benefit

Brands

  • DOXPER: AI-powered digital pen and encoded paper solution for healthcare digitisation, enabling doctors to instantly digitise prescriptions and case sheets without workflow change.
  • DOXPER BLU

Products and services

  • Doxper Digital Pen & Cloud Digitisation Platform AI-powered digital pen (Doxper and Doxper Blu with Bluetooth) paired with mobile apps (DOXPER and DOXPER BLU) and a HIPAA-compliant cloud platform that captures handwritten prescriptions and case sheets in real-time via Bluetooth and stores them in a structured digital format. Sold via annual (Rs 15,000) or monthly (Rs 1,500) subscription for individual clinics and hospitals; 30-day free trial available.
  • Doxper Encoded Paper (Doxper Prints) Coded/printed paper sheets with a unique PageID that work with the Doxper digital pen for handwriting capture. Available as single-side A4 (Rs 4) and double-side A4 (Rs 6) with a minimum order quantity of 1,000 prints and pan-India delivery. Offered with specialty-specific structured templates for Cardiology, Dental, Dermatology, ENT, Gynaecology, Internal Medicine, Neurology, Oncology, Ophthalmology, Paediatrics, and Psychiatry.
  • Real World Data & Analytics Service Analytics service providing anonymised, unbiased, and longitudinal Rx insights from digitised outpatient prescriptions. Used by pharmaceutical companies for real-world evidence generation, Rx audits, brand performance tracking, KOL engagement, disease surveillance, and pharmacovigilance. Supports monthly anonymised Rx datasets and custom digitised Rx templates for therapy areas and geographies (e.g., Africa).
  • ABDM Integration Services Integration with India's Ayushman Bharat Digital Mission enabling ABHA (Ayushman Bharat Health Account) creation and health records linking for patients. Included with subscriptions and offered as part of compliance enablement for participating healthcare providers. Doxper became one of the first tech players fully integrated with ABDM.

Quantifiable outcome

  • 96% adoption rate within 6 weeks average
  • +4 more outcomes

Companies that use Doxper

Customer profile

Named customers15 records

Segments4 records

Ideal customer profiles3 records

Doxper technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability7 records

Feature5 records

Doxper partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered minor, flagship and core.

  • Eshwar Foundation & Welfare SocietyminorStrategic or Co-development Partner · 1 January 2023Social endeavour to bring quick and cost-effective healthcare digitisation to remote areas on outskirts of Bangalore.
  • National Health Authority (NHA) - ABDMflagshipStrategic or Co-development Partner · 13 May 2022Doxper is one of the first tech players fully integrated with India's Ayushman Bharat Digital Mission (ABDM). Participates in NHA technology partner conventions to shape India's digital health ecosystem.
  • MeddoflagshipStrategic or Co-development Partner · 3 August 2021Gurugram-based healthtech startup acquired Doxper in a cash and stock deal. Combined entity became one of India's largest healthtech players in outpatient care space with 1.5 crore+ digitised prescriptions and 1 crore+ patients.
  • Pharma company partnerships (Bangladesh)coreChannel Partner/ Reseller/ Distributor · 1 June 2021Partnership with pharma company since June 2021 to sponsor Doxper solution for 3,000+ doctors in Bangladesh. Crossed 2 million Rx milestone. Scale-up to additional doctors.
  • Korean e-pharmacy startupminorChannel Partner/ Reseller/ Distributor · 5 December 2018First major overseas order and partnership secured through K-Startup Grand Challenge programme. Partnership with fast-growing e-pharmacy startup in Korea.
  • Biocon FoundationcoreStrategic or Co-development Partner · 16 February 2017Partnership for oral cancer screening at scale using Doxper's digital pen solution with ASHA workers. Data captured in local language (Kannada), analytics and insights generation provided. Over 5,000 patients screened.

Scale indicators17 records

Recent moves6 records

Expansion highlights6 records

Doxper competitors and assessment

Company assessment

Broad incumbents

  • Practo: Practo is a broader digital health platform in India offering practice management, EMR, telemedicine, and appointments. While not a direct smart pen competitor, Practo competes in digitising Indian physicians' workflows and is a much larger incumbent in the same customer base.
  • MFine: MFine is an Indian digital health platform offering online consultations, EMR, and AI-driven health services. Comparable as a healthcare IT player targeting Indian physicians and outpatient digitisation, though focused more on telehealth than handwriting capture.
  • Napier Healthcare: Napier Healthcare provides hospital information systems and EMR solutions for hospitals across emerging markets including India. Comparable as a healthcare IT vendor competing for the same hospital digitisation RFPs as Doxper's enterprise offering.
  • Tata 1mg (1mg): Tata 1mg is a leading Indian digital health platform with e-pharmacy, diagnostics, and physician consultation services. While broader than Doxper, it increasingly competes for outpatient digitisation workflows and physician data relationships.
  • Attune Technologies: Attune Technologies is a cloud-based healthcare IT platform providing HIS/EMR solutions for hospitals across India and emerging markets. A direct competitor in the hospital digitisation space where Doxper's hospital integration module competes.

Direct peers

  • DocOn: DocOn provides digital prescription and clinic management software for Indian doctors, including smart pen-based digitisation. Directly comparable to Doxper's clinic-focused digitisation offering, serving solo practitioners and small clinics in India.
  • Livescribe: Livescribe pioneered smart pen and digitised paper technology for general note-taking, the same core technology category as Doxper's smart digital pen. While Livescribe is consumer/education-focused and Doxper is healthcare-focused, they share the underlying digitised handwriting capture approach.
  • HealthStack (by Clairco): HealthStack provides digital health infrastructure including EMR/HIS solutions for Indian hospitals and clinics. Directly comparable as a healthcare digitisation platform targeting similar enterprise hospital customers as Doxper.

Emerging players

  • CrelioHealth (formerly LiveHealth): CrelioHealth is a digital health platform focused on diagnostic centres and patient records management in India. Comparable as a healthtech platform serving outpatient and diagnostic workflows with overlap on patient data management.

Others

  • Meddo: Meddo is Doxper's parent company (acquired Aug 2021), operating an integrated outpatient care platform. Relevant as the strategic acquirer/operator of Doxper's platform and a reference point for how Doxper's technology is being commercialised in a larger healthtech context.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Doxper social profiles

Digital presence

Doxper compliance and trust

Trust signal

Compliance1 record

Doxper financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Doxper leadership team

Management profile

Number of profiles

Profiles5 records

Doxper funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Doxper M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Doxper

What does Doxper do?

Doxper provides an AI-powered digital pen and encoded paper solution that allows doctors to digitise handwritten prescriptions and case sheets in real-time without changing their clinical workflow. The bundled offering includes a Bluetooth-enabled digital pen (Doxper and Doxper Blu), mobile applications, a HIPAA-compliant cloud platform with specialty-specific structured templates, and integration with India's Ayushman Bharat Digital Mission (ABDM).

Is Doxper a public or private company?

Doxper is a private company. It is classified as corporate owned and is currently acquired.

When was Doxper founded?

Doxper was founded in 2015. It employs 51 to 100 people.

Where is Doxper based?

Doxper is headquartered in Gurugram, India, in the Asia region.

How does Doxper make money?

Four revenue lines are on record. Subscription Fees are the primary driver. The others are doxper Prints (Consumables), template Customisation and pen Security Deposit.

Who are Doxper's main competitors?

Broad incumbents on record are Practo, MFine, Napier Healthcare, Tata 1mg (1mg) and Attune Technologies. Direct peers are DocOn, Livescribe and HealthStack (by Clairco). CrelioHealth (formerly LiveHealth) is listed as an emerging player. Meddo is listed as an others.

Does Doxper have an API?

No public API is recorded for Doxper.

What industry is Doxper in?

Doxper's product category is Healthcare Documentation Software. Its primary akta.pro industry code is HLACANAM, DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms, with a secondary code of HDAAAEAD, Optical Character Recognition (OCR) & Document Vision. Its NAICS code is 541511 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BusinessLineOPD care provider Meddo acquires Doxper in a cash and stock dealMeddo announced its acquisition of Doxper in a cash and stock deal on Tuesday, which aims to enhance its position in the outpatient care sector. With this acquisition, Meddo expects to scale up its branded clinics to over 1,000 in the next 12-15 months and serve more than 1 crore patients, significantly expanding its services. The company aims to transform outpatient care in India by leveraging Doxper's prescription technology.Inc42Healthtech Startup Meddo Acquires Digital Prescription Platform DoxperDigital outpatient care platform Meddo has announced the acquisition of digital prescription platform Doxper in a cash and stock deal. With this integration, Meddo plans to scale its network to over 1,000 digitized clinics across 10 cities in India within the next 12-15 months.Express HealthcareMeddo acquires Doxper in cash and stock dealMeddo has acquired Doxper in a cash and stock deal to consolidate its position as a leading health-tech provider in India's outpatient care sector. Following the acquisition, Meddo plans to expand its network of branded clinics to over 1,000 locations within the next 12-15 months across the country's top-tier markets.The Times of IndiaMeddo: Healthcare startup Meddo may acquire Doxper - The Economic TimesMeddo is in advanced talks to fully acquire Doxper, a healthcare startup that digitizes prescriptions. Meddo recently raised $6 million in a round led by SRI Capital, Picus Capital, and Alkemi Capital. Doxper has collaborated with over 2,000 clinics and 40 hospitals since 2015.The Economic TimesHow this startup is using pen and paper to transform India’s healthcare industryDoxper, a startup founded in 2015, uses pen-and-paper with AI handwriting recognition to digitize India's healthcare records. It has signed 2000 clinics and 40 hospitals, processing nearly 6 lakh prescriptions monthly, and raised $4 million in a Series A. The company plans to expand internationally to the Middle East, Africa, and Southeast Asia.MintHealth-tech startup Doxper raises $4 million as part of Series ADoxper raised $4 million in a Series A round led by Alkemi Venture Partners, with participation from Rainforest Venture Network and growX Ventures. The health-tech startup serves over 1,600 clinicians and 20 hospitals, processing about 500,000 case sheets monthly and digitizing records for over 3.25 million patients.